Spotting fake images in scientific research: insights from science integrity consultant Elisabeth Bik
Elisabeth Bik discusses the importance of science integrity and the issue of manipulated images within scientific publications.
Representing the patient voice in rare diseases: an interview with patient advocate Dakota Fisher-Vance
Dakota Fisher-Vance shares her perspectives on the role of patient advocacy in rare diseases.
What’s new in GPP 2022? Insights from lead author Lisa DeTora
Lead author of GPP 2022, Lisa DeTora, shares her views on some of the key principles outlined in the updated guidelines.
Considering sex and gender in medical research: insights from the lead author of the SAGER guidelines
Read Shirin Heidari’s thoughts on the importance of incorporating sex and gender dimensions in clinical research design and reporting.
Plain language summaries and patient involvement in publications: insights from a publisher
Laura Dormer shares her experiences of developing plain language summaries and discusses the value of patient involvement in publications.
An interview with Valérie Philippon: beyond clinical trial data
Valérie Philippon shares her perspectives on the value of including data beyond those generated in clinical trials in publication plans.
What is health literacy and why does it matter? Insights from health literacy expert Becca Freed
Health literacy expert, Becca Freed, shares her views on why heath literacy is so important and how we can promote clear medical communications for all.
The ISMPP authorship algorithm: standardising the application of the ICMJE authorship criteria
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
How to combat health misinformation: insights from a communication and human behaviour expert
Read Brian Southwell’s perspective on what can be done to prevent misinformation and build public trust in science.
Patient partnerships in the COVID-19 era and beyond: insights from a Patient Engagement Champion
Read about Trishna Bharadia’s experiences with patient collaborations. What has been the impact of COVID-19, and how does she see the future of patient partnerships?
The evolving role of medical communications professionals: insights from a Publication Lead
Publication Lead Chris Brooks discusses the impact of COVID-19 on medical communications.
Overcoming scientific communication challenges during COVID-19: insights from a Global Publications Director
Read Lucy Turner’s perspective on the impact of COVID-19 on medical publications and congresses.
How to achieve inclusivity and diversity in medical research: insights from a disability activist
Read Becca Wilson’s perspectives on the current reality and future opportunities for disability inclusivity in medical research and communications.
Combatting research integrity breaches: insights from Suzanne Farley, Director of the Springer Nature Research Integrity Group
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
Research integrity in the COVID-19 era: insights from Retraction Watch co-founder Ivan Oransky
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
The future of data sharing: insights from PLOS’ Director, Open Research Solutions
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.